Sign in

Enrollment Velocity and Site Activation Forecasting

Predicts enrollment pace and site ramp-up risk for earlier intervention and reallocation Evidence basis: Historical trial ML models can forecast recruitment efficiency and trial duration from planned study attributes; FDA risk-based monitoring guidance supports continuous use of risk indicators when combined with human review

The Problem

“Forecast enrollment velocity and site activation risk to prevent clinical trial delays”

Organizations face these key challenges:

1

Site selection is often based on incomplete or inconsistent evidence

2

Enrollment issues are detected too late to intervene efficiently

3

Startup and activation milestones are fragmented across CTMS, EDC, and spreadsheets

4

Protocol complexity and competing trials create nonlinear enrollment effects that are hard to model manually

5

Operational teams lack a single risk score with explainable drivers

6

Forecasts are not refreshed continuously as new site and study data arrive

7

Intervention prioritization is inconsistent across studies and regions

Impact When Solved

Earlier identification of underperforming or delayed sites before milestone misses compoundHigher confidence in site selection for priority indications and geographiesFaster intervention planning for startup bottlenecks, low screening yield, and enrollment slowdownReduced timeline slippage and lower cost of reactive rescue actionsBetter portfolio planning through study-level scenario forecasting and resource reallocationHuman-reviewable risk indicators aligned with risk-based monitoring practices

The Shift

Before AI~85% Manual

Human Does

  • •Collect site activation updates and enrollment counts from study teams
  • •Review spreadsheets to compare actual enrollment against plan
  • •Discuss slow-start sites and decide where to focus follow-up
  • •Reallocate outreach and startup effort based on periodic reviews

Automation

  • •No AI-driven forecasting or risk prioritization is used
  • •No automated monitoring of enrollment pace or site ramp-up trends
  • •No system-generated alerts for likely delays or underperforming sites
With AI~75% Automated

Human Does

  • •Review forecasted enrollment and site ramp-up risks with operational context
  • •Approve intervention plans and resource reallocation for at-risk sites
  • •Handle exceptions where forecasts conflict with recent field updates

AI Handles

  • •Monitor enrollment pace and site activation progress on an ongoing basis
  • •Forecast likely recruitment velocity and site ramp-up risk from study attributes and performance trends
  • •Prioritize sites and studies needing earlier intervention or support
  • •Generate alerts and recommended focus areas for operational review

Operating Intelligence

How Enrollment Velocity and Site Activation Forecasting runs once it is live

AI runs the first three steps autonomously.

Humans own every decision.

The system gets smarter each cycle.

Confidence89%
ArchetypeRecommend & Decide
Shape6-step converge
Human gates1
Autonomy
67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapeconverge

Step 1

Assemble Context

Step 2

Analyze

Step 3

Recommend

Step 4

Human Decision

Step 5

Execute

Step 6

Feedback

AI lead

Autonomous execution

1AI
2AI
3AI
5AI
gate

Human lead

Approval, override, feedback

4Human
6↺ Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in Enrollment Velocity and Site Activation Forecasting implementations:

Generative LLMsOther
4 mentions
Quantitative Systems Pharmacology modelsOther
4 mentions
Computational simulationsOther
3 mentions
Patient population modelsOther
3 mentions
Medidata AI Intelligent TrialsOther
2 mentions
+1 more technologies(sign up to see all)

Key Players

Companies actively working on Enrollment Velocity and Site Activation Forecasting solutions:

IQVIATWIN-GPT

Real-World Use Cases

AI-driven clinical trial site selection and enrollment forecasting

The company used AI to combine its own trial data with a much larger pool of clinical trial data so it could better predict which research sites would enroll patients well and help the trial finish on time.

predictive ranking and decision supportdeployed in a real sponsor planning workflow with reported outcome improvement.
10.0

Live enrollment risk forecasting during active studies

Once a trial is running, the system keeps checking whether enrollment is on track and warns teams early if recruitment is slowing down.

continuous monitoring and anomaly/risk detectiondeployed monitoring and forecasting workflow for active studies.
10.0

Hospital-level pharmaceutical demand forecasting for procurement and inventory planning

This use case predicts how much of each medicine a hospital will need each week using past dispensing patterns plus calendar and weather signals, helping staff order the right amount and avoid shortages or waste.

Supervised multivariate time-series/tabular regression forecasting with feature selection and hyperparameter optimizationvalidated research prototype / pilot-stage use case. the model was benchmarked on real-world data from two provincial hospitals, but broad operational deployment is not demonstrated.
10.0

Virtual or in silico trials and digital twins for clinical trial risk assessment

Create simulated patients or whole virtual trials on a computer to estimate safety, efficacy, or operational risks before or alongside real trials.

simulation-based forecasting and generative modelingearly-stage and experimental. the review presents virtual trials and digital twins as important but immature research avenues with significant validation and bias concerns.
10.0

Free access to this report